Authors
Latest:
Pharmacy Crime Watch Reduces Robbery and Rx FraudMr. Fagerman is president of the St. Joseph County (Indiana) Pharmacy Association. Sgt Ross is with the Crime Prevention Unit of the South Bend (Ind) Police Department.
Latest:
Increasing National Naloxone Access: Kentucky Is First to Open Online Naloxone RegistryWith mortality rates continuously climbing due to drug overdoses, the Kentucky Office of Drug Control Policy now provides an active online registry that allows patients to locate pharmacies that supply naloxone without a patient-specific prescription.
Latest:
Statins and Macrolide Antibiotics: Defining the RiskThe potential severity of these uncommon interactions warrants measures to avoid them.
Latest:
Theratechnologies Inc's EgriftaThe FDA approved Egrifta (tesamorelin) to treat lipodystrophy in HIV-infected patients.
Latest:
Potentially Inappropriate Prescribing of Direct-acting Oral Anticoagulants in the Veterans Health AdministrationThis study examines variations in overall use, and potentially inappropriate use, of non-warfarin direct-acting oral anticoagulants across sites within the Veterans Health Administration.
Latest:
Web Exclusive: Pharmacist Glycemic Control Team Associated With Improved Perioperative Glycemic and Utilization OutcomesImplementation of a pharmacist-led glycemic control team was associated with improved glycemic control and utilization outcomes in a population of noncritically ill surgical patients.
Latest:
New Oral Anticoagulants: Implications for Health SystemsThe new oral anticoagulants that have become available in recent years have added significant complexity to the prevention of stroke in patients with atrial fibrillation.
Latest:
Training Pharmacists to Support Their CommunitiesThe purpose of a postgraduate year one community-based residency program is to build upon a PharmD and help develop residents into community-based pharmacist practitioners with diverse patient care, leadership, and education skills.
Latest:
Pharmacist Collaborative Management of Poorly Controlled Diabetes Mellitus: A Randomized Controlled TrialDiabetes mellitus affects 23 million people in the United States. Adjusting for population age differences, survey data between 2004 and 2006 indicate that 6.6% of non-Hispanic whites, 7.5% of Asian Americans, 10.4% of Hispanics, and 11.8% of non-Hispanic blacks have diabetes mellitus.1 Totaling $174 billion in 2007, diabetes care accounts for 19% of total healthcare costs.
Latest:
Meeting the NeedThe tide of deaths due to unintentional prescription opioid toxicity must be stemmed.
Latest:
Impact of Drug Therapy Duration in Patients With Hepatitis CAdherence to drug therapy in hepatitis C increased total costs in year 1 relative to nonadherent patients, then decreased total costs in year 2.
Latest:
Large-Scale, Community-Based Trial of a Personalized Drug-Related Problem Rectification SystemA controlled trial of a system for rectifying and preventing drug-related problems was conducted to evaluate improvement in the efficiency of resource utilization.
Latest:
Medicare Part D Optimization: Potential Out-of-Pocket Savings Through Plan ReexaminationMedicare Part D plans can change their cost-sharing structure and formularies every year. As such, beneficiaries should annually reevaluate plan offerings to minimize their out-of-pocket costs.
Latest:
Can Thermal Mass Change the Cold Supply Chain?Due to constantly changing business models, various product configurations and distribution channels, there is no established standard to ensure that a product administered to a patient is not compromised.Â
Latest:
Future Directions for the Treatment of CLLBhavesh Shah, RPh, BCOP, and Ryan Jacobs, MD, discuss emerging agents in the pipeline and the future treatment landscape for CLL.
Latest:
Riluzole Shows No Efficacy as a Neuroprotective Agent in Patients with Early-Stage Relapsing Remitting Multiple SclerosisNegative findings were reported for both clinical and imaging measures in a Phase II randomized trial of riluzole in comparison to placebo in patients with very early multiple sclerosis (MS).
Latest:
Oxandrolone for Management of Hypercatabolism in Severe BurnsA case involving a 69-year-old man who is admitted to the burn center for management following a 31% full thickness burn and begins to lose significant lean body mass.
Latest:
Basaglar Receives Tentative FDA Approval for Diabetes TreatmentA new drug was recently given tentative approval by the FDA to help patients with both type 1 and type 2 diabetes.
Latest:
Discussing Medication Adherence with a Hospitalized PatientMedication adherence is defined as the act of patients taking their medications as prescribed by their health care provider.
Latest:
Clues Found to Long-Term HIV SuppressionSouth African child with HIV reaches 8-plus year survival after only 40 weeks of antiretroviral therapy in infancy.
Latest:
Variation in the Coverage of Disease-Modifying Multiple Sclerosis Drugs Among US PayersAn examination of payer coverage for multiple sclerosis drugs shows variation in how these drugs are covered and in the evidence that payers review to make these decisions.
Latest:
Evidence: Vital but Seldom Used Consistently by PayersPeer-reviewed research conducted by the National Pharmaceutical Council (NPC) and the Center for the Evaluation of Value and Risk in Health at Tufts Medical Center over the past 2 years sheds some light on what’s behind discrepancies in coverage decisions from one insurer to the next.
Latest:
What Advice Would You Give to Patients?Cancer patient Beth Wallace provides advice to patients with leiomyosarcoma, as well as to women with cancer in general.
Latest:
Good Intentions: Writing the Letter of IntentSo, the initial meet and greet at Mid-Year went well. You have selected the 'perfect' program. Now, it is time to declare that intention in writing.
